Published in Tuberculosis (Edinb) on November 03, 2012
Diabetes and immunity to tuberculosis. Eur J Immunol (2014) 1.45
Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology (2015) 1.17
Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis (Edinb) (2013) 1.07
The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis. PLoS One (2015) 1.05
Impact of diabetes on the natural history of tuberculosis. Diabetes Res Clin Pract (2014) 1.00
Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia. PLoS One (2014) 0.93
New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics. Immunol Rev (2015) 0.90
Tuberculosis and diabetes mellitus - an underappreciated association. Arch Med Sci (2014) 0.88
Association of Pulmonary Tuberculosis and Diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000-2012. PLoS One (2015) 0.84
Differential expression of monocyte surface markers among TB patients with diabetes co-morbidity. Tuberculosis (Edinb) (2013) 0.83
Host susceptibility factors to bacterial infections in type 2 diabetes. PLoS Pathog (2013) 0.83
Results of the implementation of a pilot model for the bidirectional screening and joint management of patients with pulmonary tuberculosis and diabetes mellitus in Mexico. PLoS One (2014) 0.81
Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids. J Diabetes Res (2015) 0.79
The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosis. PLoS One (2015) 0.77
Glycemic Control and the Risk of Tuberculosis: A Cohort Study. PLoS Med (2016) 0.76
Diabetes as an increasingly common comorbidity among patient hospitalizations for tuberculosis in the USA. BMJ Open Diabetes Res Care (2016) 0.75
Diabetes and Tuberculosis. Microbiol Spectr (2016) 0.75
Diabetes mellitus and latent tuberculosis infection: a systemic review and meta-analysis. Clin Infect Dis (2016) 0.75
Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment. Tuberculosis (Edinb) (2016) 0.75
NK-CD11c+ Cell Crosstalk in Diabetes Enhances IL-6-Mediated Inflammation during Mycobacterium tuberculosis Infection. PLoS Pathog (2016) 0.75
Influence of diabetes mellitus on the immunity to human tuberculosis. Immunology (2017) 0.75
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med (2008) 9.31
Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature (2009) 8.09
Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol (1990) 5.39
Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol (1993) 4.23
Molecular organization and function of the complement system. Annu Rev Biochem (1988) 3.91
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med (2005) 3.82
Tests of glycemia in diabetes. Diabetes Care (2004) 3.03
Infection and diabetes: the case for glucose control. Am J Med (1982) 2.90
Macrophage receptors for Mycobacterium tuberculosis. Infect Immun (1998) 2.42
Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med (1997) 2.31
Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med (1997) 2.09
Tuberculosis susceptibility of diabetic mice. Am J Respir Cell Mol Biol (2007) 2.03
Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases. Bull World Health Organ (2011) 1.95
Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun (1998) 1.74
Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals. Clin Exp Immunol (1973) 1.68
The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis (2007) 1.58
Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. J Immunol (2010) 1.48
Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract (1995) 1.27
Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am J Med Sci (1972) 1.27
Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. J Pharmacol Exp Ther (2010) 1.12
Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes. J Leukoc Biol (2006) 1.10
Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect Immun (2004) 1.09
Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest (2012) 1.06
CD14+ monocytes are vulnerable and functionally impaired under endoplasmic reticulum stress in patients with type 2 diabetes. Diabetes (2009) 1.05
Entry of Mycobacterium tuberculosis into mononuclear phagocytes. Curr Top Microbiol Immunol (1996) 1.01
Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus. Hum Immunol (2011) 0.98
Phagocytotic activity of monocytes from diabetic patients. Diabetes Care (1989) 0.97
Defective monocyte chemotactic responses in diabetes mellitus. J Clin Immunol (1983) 0.94
Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.92
Mycobacterium tuberculosis and the complement system. Trends Microbiol (1998) 0.91
Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus. J Transl Med (2012) 0.90
Monocyte functions in diabetes mellitus. Acta Pathol Microbiol Immunol Scand C (1982) 0.90
Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonising proteins. J Clin Pathol (1984) 0.89
Impairment of monocyte "lectin-like" receptor activity in type 1 (insulin-dependent) diabetic patients. Diabetologia (1987) 0.85
Intracellular hydrogen peroxide production by peripheral phagocytes from diabetic patients. Dissociation between polymorphonuclear leucocytes and monocytes. Clin Exp Immunol (1992) 0.84
Impaired function of antibodies to pneumococcal surface protein A but not to capsular polysaccharide in Mexican American adults with type 2 diabetes mellitus. Clin Vaccine Immunol (2012) 0.82
Antigenic variation by Borrelia hermsii occurs through recombination between extragenic repetitive elements on linear plasmids. Mol Microbiol (2006) 2.91
The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med (2005) 2.50
Socioeconomic status and prevalence of obesity and diabetes in a Mexican American community, Cameron County, Texas, 2004-2007. Prev Chronic Dis (2010) 2.43
Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis. Autophagy (2011) 2.06
Innate immune gene polymorphisms in tuberculosis. Infect Immun (2012) 1.89
Caspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria with lysosomes by modulating actin polymerization. Immunity (2012) 1.77
Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. PLoS Pathog (2013) 1.71
Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect Immun (2006) 1.68
Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. PLoS One (2008) 1.67
Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances. Clin Infect Dis (2007) 1.63
Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proc Natl Acad Sci U S A (2011) 1.62
Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J Immunol (2002) 1.56
MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. PLoS One (2009) 1.55
Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas. Am J Trop Med Hyg (2006) 1.53
Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinb) (2010) 1.50
Epidemiology of tuberculosis in young children in the United States. Pediatrics (2014) 1.49
Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. J Immunol (2008) 1.49
Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J Leukoc Biol (2007) 1.46
Pathogen escape from host immunity by a genome program for antigenic variation. Proc Natl Acad Sci U S A (2006) 1.44
Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. J Immunol (2006) 1.41
Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis (2008) 1.40
AcpA is a Francisella acid phosphatase that affects intramacrophage survival and virulence. Infect Immun (2006) 1.39
Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP. PLoS Pathog (2006) 1.38
Modeling the immune rheostat of macrophages in the lung in response to infection. Proc Natl Acad Sci U S A (2009) 1.38
Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses. J Immunol (2010) 1.37
Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J Immunol (2008) 1.36
Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization. Cell Microbiol (2011) 1.25
Francisella tularensis induces IL-23 production in human monocytes. J Immunol (2007) 1.24
Intraphagosomal Mycobacterium tuberculosis acquires iron from both extracellular transferrin and intracellular iron pools. Impact of interferon-gamma and hemochromatosis. J Biol Chem (2002) 1.24
NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages. Cell Microbiol (2010) 1.24
Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol (2002) 1.23
Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity and Disease. Front Immunol (2013) 1.21
Meeting Report: NIH Workshop on the Tuberculosis Immune Epitope Database. Tuberculosis (Edinb) (2007) 1.19
Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. J Leukoc Biol (2006) 1.13
Pulmonary surfactant protein a inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J Immunol (2004) 1.11
Evaluation of a modified interferon-gamma release assay for the diagnosis of latent tuberculosis infection in adult and paediatric populations that enables delayed processing. Scand J Infect Dis (2010) 1.10
Surfactant protein D inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination. J Immunol (2002) 1.10
The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome. J Leukoc Biol (2008) 1.10
Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect Immun (2004) 1.09
Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes. J Immunol (2010) 1.07
Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan. J Biol Chem (2008) 1.05
Francisella gains a survival advantage within mononuclear phagocytes by suppressing the host IFNgamma response. Mol Immunol (2008) 1.04
Macrophages in tuberculosis: friend or foe. Semin Immunopathol (2013) 1.04
Regulation of francisella tularensis virulence. Front Microbiol (2011) 1.03
Role of STAT1, NF-kappaB, and C/EBPbeta in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN-gamma. J Leukoc Biol (2009) 1.02
Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant. Vaccine (2011) 1.02
Surfactant protein D increases fusion of Mycobacterium tuberculosis-containing phagosomes with lysosomes in human macrophages. Infect Immun (2006) 1.01
Overexpression of Mycobacterium tuberculosis manB, a phosphomannomutase that increases phosphatidylinositol mannoside biosynthesis in Mycobacterium smegmatis and mycobacterial association with human macrophages. Mol Microbiol (2005) 1.00
Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent. Antimicrob Agents Chemother (2009) 0.98
Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent. J Biomed Sci (2009) 0.97
MiR-155 induction by microbes/microbial ligands requires NF-κB-dependent de novo protein synthesis. Front Cell Infect Microbiol (2012) 0.96
Akt and SHIP modulate Francisella escape from the phagosome and induction of the Fas-mediated death pathway. PLoS One (2009) 0.95
A bacterial protein promotes the recognition of the Legionella pneumophila vacuole by autophagy. Eur J Immunol (2013) 0.95
Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death. Glycobiology (2009) 0.94
Structural differences in lipomannans from pathogenic and nonpathogenic mycobacteria that impact CD1b-restricted T cell responses. J Biol Chem (2011) 0.93
Mannose receptor-dependent delay in phagosome maturation by Mycobacterium avium glycopeptidolipids. Infect Immun (2009) 0.93
Similar diagnostic performance for neurocysticercosis of three glycoprotein preparations from Taenia solium metacestodes. Am J Trop Med Hyg (2003) 0.92
Characterization of "Mycobacterium paraffinicum" associated with a pseudo-outbreak. J Clin Microbiol (2008) 0.92
Rapid DNA extraction for specific detection and quantitation of Mycobacterium tuberculosis DNA in sputum specimens using Taqman assays. Tuberculosis (Edinb) (2011) 0.91
Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages. Am J Physiol Lung Cell Mol Physiol (2012) 0.91
The nature of extracellular iron influences iron acquisition by Mycobacterium tuberculosis residing within human macrophages. Infect Immun (2004) 0.90
Diagnosis of tuberculosis lymphadenitis using a polymerase chain reaction on peripheral blood mononuclear cells. Am J Trop Med Hyg (2003) 0.90
Validation of Mycobacterium tuberculosis Rv1681 protein as a diagnostic marker of active pulmonary tuberculosis. J Clin Microbiol (2013) 0.89
Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis (Edinb) (2011) 0.89
Structural characterization of the N-linked glycans from Taenia solium metacestodes. Mol Biochem Parasitol (2003) 0.86
Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection. J Immunol (2011) 0.86
A mathematical model of CR3/TLR2 crosstalk in the context of Francisella tularensis infection. PLoS Comput Biol (2012) 0.86
The inflammatory cell infiltrates in porcine cysticercosis: immunohistochemical analysis during various stages of infection. Vet Parasitol (2002) 0.85
Critical role of amino acid position 343 of surfactant protein-D in the selective binding of glycolipids from Mycobacterium tuberculosis. Glycobiology (2009) 0.84
The acid phosphatase AcpA is secreted in vitro and in macrophages by Francisella spp. Infect Immun (2011) 0.84
Mycobacterium tuberculosis binding to human surfactant proteins A and D, fibronectin, and small airway epithelial cells under shear conditions. Infect Immun (2006) 0.84
Pulmonary surfactant protein A activates a phosphatidylinositol 3-kinase/calcium signal transduction pathway in human macrophages: participation in the up-regulation of mannose receptor activity. J Immunol (2005) 0.83
Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus. Mol Immunol (2012) 0.82
Gallium nitrate is efficacious in murine models of tuberculosis and inhibits key bacterial Fe-dependent enzymes. Antimicrob Agents Chemother (2013) 0.82
Molecular composition of the alveolar lining fluid in the aging lung. Age (Dordr) (2014) 0.81
Modeling the host response to inhalation anthrax. J Theor Biol (2011) 0.81
Mutation in the DC-SIGN cytoplasmic triacidic cluster motif markedly attenuates receptor activity for phagocytosis and endocytosis of mannose-containing ligands by human myeloid cells. J Leukoc Biol (2008) 0.81
Pharmacological exploitation of an off-target antibacterial effect of the cyclooxygenase-2 inhibitor celecoxib against Francisella tularensis. Antimicrob Agents Chemother (2009) 0.81
Complement protein C3 binding to Bacillus anthracis spores enhances phagocytosis by human macrophages. Microb Pathog (2009) 0.81
Pseudo-outbreak of "Mycobacterium paraffinicum" infection and/or colonization in a tertiary care medical center. Infect Control Hosp Epidemiol (2009) 0.80
N-glycolylated peptidoglycan contributes to the immunogenicity but not pathogenicity of Mycobacterium tuberculosis. J Infect Dis (2013) 0.80
Endocytic pathway for surfactant protein A in human macrophages: binding, clathrin-mediated uptake, and trafficking through the endolysosomal pathway. Am J Physiol Lung Cell Mol Physiol (2005) 0.80
In situ detection of antigenic glycoproteins in Taenia solium metacestodes. J Parasitol (2003) 0.79
Toward Resolving the Paradox of the Critical Role of the DosR Regulon in Mycobacterium tuberculosis Persistence and Active Disease. Am J Respir Crit Care Med (2015) 0.79
Comparative transcriptional study of the putative mannose donor biosynthesis genes in virulent Mycobacterium tuberculosis and attenuated Mycobacterium bovis BCG strains. Infect Immun (2011) 0.79
Concerns about "Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study". Clin Infect Dis (2009) 0.79
Changes in the major cell envelope components of Mycobacterium tuberculosis during in vitro growth. Glycobiology (2013) 0.78
Tuberculosis research: going forward with a powerful "translational systems biology" approach. Tuberculosis (Edinb) (2010) 0.78
Delivery of host cell-directed therapeutics for intracellular pathogen clearance. Expert Rev Anti Infect Ther (2013) 0.78
Systematic interpretation of molecular beacon polymerase chain reaction for identifying rpoB mutations in Mycobacterium tuberculosis isolates with mixed resistant and susceptible bacteria. Diagn Microbiol Infect Dis (2010) 0.78
Nicotine treatment improves Toll-like receptor 2 and Toll-like receptor 9 responsiveness in active pulmonary sarcoidosis. Chest (2013) 0.77
Validation of increased blood storage times with the T-SPOT.TB assay with T-Cell Xtend reagent in individuals with different tuberculosis risk factors. J Clin Microbiol (2012) 0.77
Correction: Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis. PLoS Pathog (2016) 0.75
A missed tuberculosis diagnosis resulting in hospital transmission. Infect Control Hosp Epidemiol (2014) 0.75
Characterization of clinical and environmental Mycobacterium avium spp. isolates and their interaction with human macrophages. PLoS One (2012) 0.75
New concepts in understanding latent tuberculosis. Curr Opin Infect Dis (2017) 0.75
Serological screening for cysticercosis in mentally altered individuals. Trop Med Int Health (2002) 0.75
Innate Immune Responses to Tuberculosis. Microbiol Spectr (2016) 0.75